Childhood-onset Obsessive-compulsive disorder (OCD) and tic disorders, including Tourette disorder, arise from a variety of etiologies. A subgroup of patients with symptom exacerbations triggered by Group A beta-hemolytic streptococcal infections (GABHS) has been identified and labelled PANDAS for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections. Systematic studies of phenomenology, treatment and prevention are ongoing. Over 50 children and adolescents have been examined and their clinical presentation reported (1). The children are young (average age of symptom onset = 6.5 years), predominantly male (boys: girls = 2.6:1) and by definition, have an episodic course with symptom exacerbations associated with GABHS infections. Two studies were completed during the reporting period. The first examined the effectiveness of immunomodulatory treatments - plasmapheresis and intravenous immunoglobulin (IVIG) in comparison with placebo (sham IVIG) treatment. Data analysis is near completion for the first 29 subjects and preliminary results show that the active treatments were strikingly and significantly superior to placebo, with the average improvement exceeding 50% on some measures at one-month follow-up. The second study, an eight month long double-blind crossover trial, examined the effectiveness of penicillin prophylaxis for prevention of symptom exacerbations in children with PANDAS. Penicillin was slightly better than placebo in preventing GABHS infections and in improving overall behavior. Of interest, antistreptococcal titers rose frequently in both phases of the study. Although poor compliance might be blamed, the break-through infections suggest that PenV-K may not be sufficient prophylaxis against GABHS for rheumatic fever, as well as PANDAS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH002666-06
Application #
6111180
Study Section
Special Emphasis Panel (PDN)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Kalra, Simran K; Swedo, Susan E (2009) Children with obsessive-compulsive disorder: are they just ""little adults""? J Clin Invest 119:737-46
Murphy, Tanya K; Snider, Lisa A; Mutch, P Jane et al. (2007) Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry 61:279-84
Grant, Paul; Lougee, Lorraine; Hirschtritt, Matthew et al. (2007) An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 17:761-7
Kirvan, Christine A; Cox, Carol J; Swedo, Susan E et al. (2007) Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol 178:7412-21
Stein, Dan J; Arya, Monisha; Pietrini, Pietro et al. (2006) Neurocircuitry of disgust and anxiety in obsessive-compulsive disorder: a positron emission tomography study. Metab Brain Dis 21:267-77
Kirvan, Christine A; Swedo, Susan E; Kurahara, David et al. (2006) Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 39:21-9
Kirvan, Christine A; Swedo, Susan E; Snider, Lisa A et al. (2006) Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 179:173-9
Snider, Lisa A; Lougee, Lorraine; Slattery, Marcia et al. (2005) Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 57:788-92
Swedo, Susan E; Grant, Paul J (2005) Annotation: PANDAS: a model for human autoimmune disease. J Child Psychol Psychiatry 46:227-34
Asbahr, Fernando R; Garvey, Marjorie A; Snider, Lisa A et al. (2005) Obsessive-compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry 57:1073-6

Showing the most recent 10 out of 34 publications